Camelia Epuran

Dr. Camelia Epuran


Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 April 2026 in Polymers
Verified
Journal Article
Open access
PDF file
CICamelia-Daniela Ionaș
Camelia-Daniela Ionaș
DODorinel Okolišan
Dorinel Okolišan
CECamelia Epuran
Camelia Epuran
IFIon Fratilescu
Ion Fratilescu
GVGabriela Vlase
Gabriela Vlase
Vlase TitusVlase Titus
Vlase Titus
Flunarizine is a calcium channel blocker widely used in neurological disorders; however, its low aqueous solubility may influence formulation stability and drug dispersion in polymer-based systems. The present study aimed to evaluate the compatibility of flunarizine with selected excipients and to investigate its incorporation into polymeric hydrogel matrices. Binary mixtures of flunarizine with excipients such as hydroxypropyl-β-cyclodextrin, polyethylene glycol (PEG 6000), Tween 20, gelatin, and citric acid were prepared and characterized using Fourier-transform infrared spectroscopy (FTIR), thermogravimetric analysis (TG/DTG), and high-performance liquid chromatography (HPLC). The FTIR spectra of the analyzed samples do not reveal the appearance of new absorption bands that may indicate chemical interactions; instead, minor spectral variations were observed due to weak intermolecular interactions within the polymer network. Thermal analysis revealed decomposition patterns consistent with those of the individual components, suggesting the absence of significant incompatibilities. A validated RP-HPLC method enabled sensitive and reliable quantification of flunarizine in the analyzed systems, with a limit of detection (LOD) of 0.05 µg/mL and a limit of quantitation (LOQ) of 0.16 µg/mL. Accuracy testing showed average recovery rates of 100% across 80–120% spiking levels. Overall, the results support the compatibility of flunarizine with the investigated excipients and the suitability of the studied hydrogels as potential drug delivery matrices.

22 July 2026 in Molecules
Verified
Journal Article
Open access
PDF file
IGIulia Gallo
Iulia Gallo
CECamelia Epuran
Camelia Epuran
IFIon Fratilescu
Ion Fratilescu
RȘRaul Ștefan-Pantiș
Raul Ștefan-Pantiș
Alexandru PahomiAlexandru Pahomi
Alexandru Pahomi
GVGabriela Vlase
Gabriela Vlase
Oral administration of narrow therapeutic index anticoagulants like phenprocoumon (PHP) necessitates careful control of the kinetic release of the drug to avoid dose dumping and severe haemorrhagic effects. This study was carried out to prepare and characterize novel PHP delivery systems based on κ-carrageenan hydrogels, exploring the importance of potassium ion (K+) stabilization in controlling the release process. FT-IR, TG/DTG, and in vitro release studies were employed in combination with a new validated RP-HPLC assay. FT-IR and thermal analysis results showed that PHP is physically encapsulated into the polysaccharide matrix, where there are no chemical incompatibilities between them. Furthermore, potassium ions increase the stability and heat resistance of the polymer network. However, when K+ was considered for modelling the kinetic release using the Korsmeyer–Peppas equation, it was observed that PHP is released from the K+ stabilized matrix in a relaxation dominated diffusion-controlled transport. Ionic cross-linking effectively reduces the initial burst effect, demonstrating that these matrices are promising vehicles for the sustained delivery of phenprocoumon.